Alliance Pharma plc

LSE APH.L

Alliance Pharma plc Free Cash Flow Yield on January 14, 2025: 9.69%

Alliance Pharma plc Free Cash Flow Yield is 9.69% on January 14, 2025, a -31.56% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
  • Alliance Pharma plc 52-week high Free Cash Flow Yield is 19.55% on May 08, 2024, which is 101.75% above the current Free Cash Flow Yield.
  • Alliance Pharma plc 52-week low Free Cash Flow Yield is 9.69% on January 13, 2025, which is -0.07% below the current Free Cash Flow Yield.
  • Alliance Pharma plc average Free Cash Flow Yield for the last 52 weeks is 14.15%.
Key data
Date Free Cash Flow Yield Market Value Added (MVA) Price to Book Ratio (P/B) Price to Earnings Ratio (P/E)
Market news
Loading...
LSE: APH.L

Alliance Pharma plc

CEO Mr. Nicholas John Sedgwick
IPO Date Nov. 22, 2001
Location United Kingdom
Headquarters Avonbridge House
Employees 290
Sector Health Care
Industries
Description

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.

Similar companies

GBG.L

GB Group plc

USD 3.98

-0.52%

DOTD.L

dotdigital Group Plc

USD 0.97

0.21%

AMS.L

Advanced Medical Solutions Group plc

USD 2.66

14.48%

IOM.L

iomart Group plc

USD 0.90

-2.54%

ABDP.L

AB Dynamics plc

USD 22.46

0.64%

StockViz Staff

January 15, 2025

Any question? Send us an email